On this page
Brachydactyly type A1
This inherited disorder affects bone development in the hands and feet, typically causing noticeable shortening of the fingers with limited impact on overall health. The condition follows an autosomal dominant pattern and is caused by changes in the IHH gene.
Overview
Brachydactyly type A1 is a rare skeletal condition in which the middle bones (middle phalanges) of the fingers are abnormally short, leading to noticeably shortened digits. The term brachydactyly comes from Greek words meaning 'short fingers'. Whilst several types of brachydactyly exist, type A1 specifically affects the middle segment of fingers and sometimes toes, with the thumb and big toe often appearing relatively normal. The condition is typically evident from birth or early childhood and remains stable throughout life rather than worsening with age.
Brachydactyly type A1 is classified as rare, though exact prevalence figures in the UK population are not well established. Because it follows an autosomal dominant inheritance pattern, affected individuals have a 50% chance of passing the condition to each of their children. For most people with this condition, the skeletal changes do not cause significant functional impairment or associated health problems, though some individuals may experience mild limitations in fine motor tasks or seek treatment for cosmetic concerns.
Symptoms & clinical features
The hallmark feature of brachydactyly type A1 is shortening of the middle phalanges, which are the bones in the middle segment of each finger. This shortening is typically most noticeable in the index, middle, and ring fingers, whilst the little finger and thumb are often less severely affected or may appear normal. The shortened finger bones result in fingers that appear stubby or disproportionately short compared to the palm. In some cases, the toes may also be affected, though hand involvement is generally more pronounced.
Most individuals with brachydactyly type A1 do not experience pain or functional difficulties related to their hand structure. Fine motor skills such as writing, typing, or playing musical instruments are generally preserved, though some people may develop their own adaptations for certain tasks. Joint mobility is typically normal, and there are usually no associated nail abnormalities. The condition does not affect growth in other parts of the body, and individuals have normal stature and skeletal development elsewhere. Some families report subtle variations in severity between affected members, with some having more pronounced shortening than others.
Video: Genetics 101
Affected organs
Brachydactyly type A1 primarily affects the skeletal system, specifically the bones of the hands and feet. The middle phalanges, which form through a process called endochondral ossification during foetal development and early childhood, fail to grow to their typical length. This occurs because the growth plates (epiphyses) in these bones close prematurely or develop abnormally, halting further lengthening.
The condition is isolated to the digits, meaning other skeletal structures such as the long bones of the arms and legs, the spine, and the skull develop normally. There is no involvement of internal organs, and the condition does not affect cognitive development, vision, hearing, or other body systems. This localised impact distinguishes brachydactyly type A1 from more complex skeletal dysplasias that may affect multiple organ systems.
Risks & severity
Brachydactyly type A1 is generally considered a mild condition with minimal impact on overall health and life expectancy. The degree of finger shortening can vary between individuals and even between different fingers in the same person, but the condition typically remains stable after skeletal maturity is reached in late adolescence. Unlike some skeletal disorders, brachydactyly type A1 does not progress or lead to degenerative changes over time.
Whilst the functional impact is usually minimal, some individuals may experience mild challenges with tasks requiring precise grip or reach. Psychological and social concerns related to hand appearance can affect some people, particularly during adolescence. There are no known associations with increased risk of arthritis, fractures, or other skeletal complications in adulthood. The condition does not affect reproductive ability or increase risks during pregnancy.
Genetic causes
Brachydactyly type A1 is caused by pathogenic variants in the IHH gene, which provides instructions for making Indian hedgehog signalling molecule. This protein plays a crucial role in skeletal development, particularly in regulating the growth and maturation of cartilage and bone. During normal development, IHH coordinates the balance between cartilage proliferation and the process by which cartilage is replaced by bone, ensuring that bones grow to their appropriate length.
Pathogenic changes in IHH disrupt this carefully orchestrated process, leading to premature closure of the growth plates in the middle phalanges. Research suggests that these variants may cause the protein to signal inappropriately, triggering early bone maturation before the phalanges have reached their normal length [PMID:15057982]. The hedgehog signalling pathway, of which IHH is a key component, is essential for multiple aspects of embryonic development, but the specific variants causing brachydactyly type A1 appear to have effects primarily limited to digit development. Different changes in the IHH gene can result in varying degrees of shortening, explaining some of the variation seen between families and individuals [PMID:11359211].
- IHH Indian hedgehog signaling molecule
Inheritance pattern
Brachydactyly type A1 follows an autosomal dominant pattern of inheritance. This means that inheriting just one altered copy of the IHH gene from either parent is sufficient to cause the condition. Each child of an affected parent has a 50% chance of inheriting the pathogenic variant and therefore developing brachydactyly type A1. The condition affects males and females equally.
In families where one parent has brachydactyly type A1, approximately half of the children will typically be affected, though chance means actual numbers may vary. Occasionally, the condition appears in a family with no previous history, which may represent a new (de novo) genetic change occurring for the first time in that individual. People with brachydactyly type A1 who are considering having children may wish to discuss inheritance risks and reproductive options with a genetic counsellor.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis of brachydactyly type A1 is typically made through clinical examination and radiographic imaging. X-rays of the hands and feet can clearly demonstrate the characteristic shortening of the middle phalanges and help distinguish type A1 from other forms of brachydactyly. A detailed family history is also important, as the autosomal dominant inheritance pattern often means multiple family members across generations are affected.
Genetic testing can confirm the diagnosis by identifying a pathogenic variant in the IHH gene. In the NHS, referral for genetic testing would typically be made through clinical genetics services. Whilst brachydactyly type A1 is not currently associated with a specific NHS Genomic Medicine Service rare disease R-code, individuals with suspected skeletal dysplasias may be referred to specialist centres for evaluation. Genetic counselling is available to discuss test results, inheritance risks, and implications for family members.
Management & lifestyle
Management of brachydactyly type A1 is generally conservative, as most individuals do not require specific medical treatment. Regular monitoring by a general practitioner or paediatrician during childhood can ensure normal growth and development in other aspects. Hand function is typically preserved, and most people adapt naturally to their hand structure without intervention.
For individuals who experience functional limitations or significant concern about hand appearance, referral to a hand surgeon or orthopaedic specialist can explore options such as surgical lengthening procedures, though these are rarely necessary and carry their own risks. Occupational therapy may occasionally be helpful for developing adaptive strategies for specific tasks. Genetic counselling is available through NHS clinical genetics services to discuss inheritance patterns, family planning, and testing options for relatives. Psychological support may benefit individuals experiencing distress related to hand appearance, particularly during adolescent years.
UK care pathway
In the UK, individuals with suspected brachydactyly type A1 can be referred to NHS clinical genetics services through their general practitioner or specialist physician. Whilst not a condition typically requiring urgent intervention, genetic counselling provides valuable information about inheritance patterns and genetic testing options. Clinical genetics teams can coordinate with orthopaedic or hand surgery specialists if functional concerns arise.
Genetic testing for IHH variants can be arranged through the NHS Genomic Medicine Service, though the clinical criteria for testing may vary. Families affected by brachydactyly type A1 benefit from access to genetic counsellors who can explain test results, discuss implications for other family members, and provide guidance about reproductive choices. Given the generally mild nature of this condition, care is often coordinated through primary care with specialist input as needed rather than requiring ongoing secondary care.
Frequently asked questions
Will my child's hands get worse as they grow older?
No, brachydactyly type A1 does not worsen over time. The shortened finger bones are present from birth or early childhood and remain stable once skeletal growth is complete in the late teens. The condition does not lead to progressive deformity or arthritis.
Can my child participate in sports and normal activities?
Yes, most children with brachydactyly type A1 can participate fully in sports, physical activities, and hobbies. Whilst finger length is reduced, hand function and grip strength are typically normal. Children usually adapt naturally to their hand structure.
Should other family members be tested?
Because brachydactyly type A1 follows an autosomal dominant pattern, siblings and children of affected individuals have a 50% chance of inheriting the condition. Genetic counselling can help families decide whether testing would be helpful, though many families recognise the condition through clinical appearance alone.
Is surgery recommended to lengthen the fingers?
Surgery is rarely necessary for brachydactyly type A1, as most people function well without intervention. Surgical lengthening procedures are complex and carry risks including infection, scarring, and prolonged rehabilitation. Decisions about surgery should be made in consultation with a hand surgeon, considering both functional needs and personal preferences.
References
- Li J, Liang X, Wang X. A missense GDF5 variant causes brachydactyly type A1 and multiple-synostoses syndrome 2. JOR spine. 2024. PMID: 38222807
- Gao B, He L. Answering a century old riddle: brachydactyly type A1. Cell research. 2004. PMID: 15225411
- Stattin EL, Lindén B, Lönnerholm T. Brachydactyly type A1 associated with unusual radiological findings and a novel Arg158Cys mutation in the Indian hedgehog (IHH) gene. European journal of medical genetics. 2009. PMID: 19464397
- Shen L, Ma G, Shi Y. p.E95K mutation in Indian hedgehog causing brachydactyly type A1 impairs IHH/Gli1 downstream transcriptional regulation. BMC genetics. 2019. PMID: 30651074
- Lacombe D, Delrue MA, Rooryck C. Brachydactyly type A1 with short humerus and associated skeletal features. American journal of medical genetics. Part A. 2010. PMID: 21077205
- Leung AOW, Poon ACH, Wang X. Suppression of apoptosis impairs phalangeal joint formation in the pathogenesis of brachydactyly type A1. Nature communications. 2024. PMID: 38472182
- Sentchordi-Montané L, Benito-Sanz S, Aza-Carmona M. Clinical and Molecular Description of 16 Families With Heterozygous IHH Variants. The Journal of clinical endocrinology and metabolism. 2020. PMID: 32311039
- Ozaki N, Okuda H, Kobayashi H. Deletion of 2 amino acids in IHH in a Japanese family with brachydactyly type A1. BMC medical genomics. 2021. PMID: 34315464